News | Events

KFPO309 - CoroPan Joint Minisymposium

Friday, 03 March 2023

Online only

Download - Agenda Minisymposium

Workshop On Single Cell Analysis

Start: Thursday, 20 October 2022
End: Friday, 21 October 2022

Frankfurter Straße 98, 35392 Gießen, Veterinärklinik, Anatomie Hörsaal, 1. OG / Raum 009; Open for all!

Download - KFO309 Workshop final 1pdf 1

9:30	Bartkuhn / Wilhelm	Welcome Note
9:45	Harald Vöhringer	The Analysis of Single Cell Data: From Prepossessing to Downstream Analysis
10:15	Leon Schulte	Decoding of the peripheral blood noncoding RNA repertoire by single cell RNA-seq
10:45	Coffee break
11:00	Gabriela Salinas	A novel single-cell RNA-sequencing approach and its applicability connecting genotype to phenotype in ageing disease
11:30	Christian Schmidl	Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating T cells
12:00	Lunch break
13:00	Arnaud Krebs	Genome-wide quantification of transcription factor binding at single-DNA-molecule resolution
13:30	Benedikt Obermayer Wasserscheid	Single cell genomics applications in COVID-19 and allogeneic hematopoietic stem cell transplantation
14:00	Coffee break
14:30	Florian Buettner	Pathway-driven dissection of cell-cell heterogeneity in single-cell RNA-seq data
15:00	Florian Tran	On the way from single cell phenotyping to spatial biology - lessons from studies in IBD
15:30	10x Genomics	TBA

Progress Reports 2022

t.b.d.

Date	Projects
February, 4th 13:30 - 15:00 h	P10 (Sommer/Skevaki) P2 (Becker/Herold)
May 6th, 12:00 - 15:00 h	P1 (Bauer/Weber) P3 (Ziebuhr/Kracht) P5 (Vadász/Samakovlis)
Sep 23rd, 12.30 - 15:00 h	P6 (Morty/Friebertshäuser/Ehrhardt) P8 (Herold/Braun)
Nov, 4th, 12.00 - 15:00 h VC	P7 (El Agha/Günther/Bellusci) P10 (Sommer/Skevaki) early career report (Müller) Z1 (Hain/Goesmann/ Wilhelm/Looso)

Ein kleines Protein gegen COVID-19

Download - Pressemitteilung

Gießener Lungenforscherinnen und -forscher testen einen Wirkstoff gegen schwere Verläufe von COVID-19 – BMBF fördert die klinische Studie mit rund 1,84 Millionen Euro

Progress Reports 2021

ECCPS Seminar Room

Aulweg 130

35392 Gießen

Date	Projects
April, 23rd 13:00 - 15:00 h	P10 (Sommer/Skevaki) P1 (Bauer/Weber)
July 2nd, 13:00 - 15:00 h	P2 (Becker/Herold) P3 (Ziebuhr/Kracht)
Sep 3rd, 12.30-15:00 h	P5 (Vadász/Samakovlis) P6 (Morty/Friebertshäuser/Ehrhardt) P7 (El Agha/Günther/Bellusci)
Dec 03rd, 12.30-14:30 h	P8 (Herold/Braun) Z1 (Hain/Goesmann/ Wilhelm/Looso)

GM-CSF study extended to COVID-19 patients

GM-CSF (granulocyte/macrophage colony-stimulating factor) was found to be highly protective in pre-clinical models of pneumonia-associated lung injury including viral infection. There is first evidence of a beneficial effect of inhaled GM-CSF in patients with severe pneumonia/ARDS.
A placebo-controlled, randomized clinical phase II investigator-initiated trial (GI-HOPE, NCT02595060) currently addresses the adjunctive therapeutic role of aerosolized GM-CSF in patients with pneumonia-related ARDS (for further details see project 9). The study was extended to COVID-19 patients, please find the BMBF report here.

All News / Events